Literature DB >> 15582191

Effect of ethanol on the tumorigenicity of urethane (ethyl carbamate) in B6C3F1 mice.

Frederick A Beland1, R Wayne Benson, Paul W Mellick, Robert M Kovatch, Dean W Roberts, Jia-Long Fang, Daniel R Doerge.   

Abstract

Urethane is a carcinogen to which there is widespread exposure through the consumption of fermented foods and alcoholic beverages. In this study, we have assessed the carcinogenicity of urethane in combination with ethanol. Male and female B6C3F(1) mice (48 mice per sex per group) were exposed to 0, 10, 30, or 90 ppm urethane in the presence of 0%, 2.5%, or 5% ethanol in drinking water ad libitum for two years, at which time the extent of tumorigenesis was assessed. Additional mice (four per sex per group) received the same doses for four weeks to assess serum levels of urethane and ethanol, DNA adduct formation, and the induction of microsomal cytochromes P450, cell proliferation, and apoptosis. Urethane decreased cell replication in the livers of female, but not male, mice, decreased cell replication in the lungs of both sexes, and induced cytochrome P450 2E1 in the livers of female mice. Hepatic levels of the DNA adduct 1,N(6)-ethenodeoxyadenosine were increased by exposure to urethane and decreased by treatment with ethanol. Animal weights and survival were not affected by ethanol; in contrast, urethane administration decreased body weights and survival. Urethane caused dose-dependent increases in liver, lung, and harderian gland adenoma or carcinoma and hemangiosarcoma of the liver and heart in both sexes, mammary gland and ovarian tumors in females, and squamous cell papilloma or carcinoma of the skin and forestomach in males. The increase in hepatocellular tumors occurred in a relatively linear manner and was attributed to the formation of 1,N(6)-ethenodeoxyadenosine in hepatic DNA coupled with an increase in cell replication. Hemangiosarcomas were observed only at the 90 ppm urethane dose and were probably a result of high-dose urethane-induced toxicity. Lung alveolar/bronchiolar and harderian gland adenoma or carcinoma increased in a relatively linear manner, suggestive of a genotoxic mechanism for tumor induction. Ethanol induced a dose-dependent trend in hepatocellular adenoma or carcinoma in male mice, with the incidence being marginally increased at the highest dose. In female mice administered 10 ppm and 90 ppm urethane, ethanol caused dose-related increases in alveolar/bronchiolar adenoma or carcinoma and hemangiosarcoma of the heart, respectively. This may be due to ethanol decreasing the first-pass clearance of urethane, thus, increasing systemic distribution. In male mice a different relationship was observed: ethanol caused a dose-related decrease in alveolar/bronchiolar and harderian gland adenoma or carcinoma in mice administered 30 ppm urethane.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15582191     DOI: 10.1016/j.fct.2004.07.018

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  27 in total

1.  Carcinogenicity of glycidamide in B6C3F1 mice and F344/N rats from a two-year drinking water exposure.

Authors:  Frederick A Beland; Greg R Olson; Maria C B Mendoza; M Matilde Marques; Daniel R Doerge
Journal:  Food Chem Toxicol       Date:  2015-09-30       Impact factor: 6.023

2.  Alcohol Intake and Breast Cancer Risk in African American Women from the AMBER Consortium.

Authors:  Lindsay A Williams; Andrew F Olshan; Chi-Chen Hong; Elisa V Bandera; Lynn Rosenberg; Ting-Yuan David Cheng; Kathryn L Lunetta; Susan E McCann; Charles Poole; Laurence N Kolonel; Julie R Palmer; Christine B Ambrosone; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-04-18       Impact factor: 4.254

Review 3.  Role of alcohol in the development and progression of hepatocellular carcinoma.

Authors:  Iain H McKillop; Laura W Schrum; Kyle J Thompson
Journal:  Hepat Oncol       Date:  2015-11-30

4.  Analysis of ethyl carbamate in plum wines produced in Korea.

Authors:  Jung-Bin Lee; Mina K Kim; Bo-Kyung Kim; Yun-Hee Chung; Kwang-Geun Lee
Journal:  Food Sci Biotechnol       Date:  2017-11-30       Impact factor: 2.391

5.  ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model.

Authors:  Stephanie E Busch; Kay E Gurley; Russell D Moser; Christopher J Kemp
Journal:  J Pathol       Date:  2012-05-08       Impact factor: 7.996

6.  Induction of Pig-a mutant erythrocytes in male and female rats exposed to 1,3-propane sultone, ethyl carbamate, or thiotepa.

Authors:  Carson Labash; Kristine Carlson; Svetlana L Avlasevich; Ariel Berg; Jeffrey C Bemis; James T MacGregor; Stephen D Dertinger
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2015-03-14       Impact factor: 2.873

7.  CAR1 deletion by CRISPR/Cas9 reduces formation of ethyl carbamate from ethanol fermentation by Saccharomyces cerevisiae.

Authors:  Young-Wook Chin; Woo-Kyung Kang; Hae Won Jang; Timothy L Turner; Hyo Jin Kim
Journal:  J Ind Microbiol Biotechnol       Date:  2016-08-29       Impact factor: 3.346

Review 8.  Cancer risk assessment of ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaça and tiquira.

Authors:  Dirk W Lachenmeier; Maria C P Lima; Ian C C Nóbrega; José A P Pereira; Florence Kerr-Corrêa; Fotis Kanteres; Jürgen Rehm
Journal:  BMC Cancer       Date:  2010-06-08       Impact factor: 4.430

9.  Chronic ingestion of ethanol induces hepatocellular carcinoma in mice without additional hepatic insult.

Authors:  Mutsumi Tsuchishima; Joseph George; Hisakazu Shiroeda; Tomiyasu Arisawa; Tsutomu Takegami; Mikihiro Tsutsumi
Journal:  Dig Dis Sci       Date:  2013-01-31       Impact factor: 3.199

10.  Ethyl carbamate in alcoholic beverages from Mexico (tequila, mezcal, bacanora, sotol) and Guatemala (cuxa): market survey and risk assessment.

Authors:  Dirk W Lachenmeier; Fotis Kanteres; Thomas Kuballa; Mercedes G López; Jürgen Rehm
Journal:  Int J Environ Res Public Health       Date:  2009-01-20       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.